Searching across hundreds of databases
The ex vivo generation of platelets from human-induced pluripotent cells (hiPSCs) is expected to compensate donor-dependent transfusion systems. However, manufacturing the clinically required number of platelets remains unachieved due to the low platelet release from hiPSC-derived megakaryocytes (hiPSC-MKs). Here, we report turbulence as a physical regulator in thrombopoiesis in vivo and its application to turbulence-controllable bioreactors. The identification of turbulent energy as a determinant parameter allowed scale-up to 8 L for the generation of 100 billion-order platelets from hiPSC-MKs, which satisfies clinical requirements. Turbulent flow promoted the release from megakaryocytes of IGFBP2, MIF, and Nardilysin to facilitate platelet shedding. hiPSC-platelets showed properties of bona fide human platelets, including circulation and hemostasis capacities upon transfusion in two animal models. This study provides a concept in which a coordinated physico-chemical mechanism promotes platelet biogenesis and an innovative strategy for ex vivo platelet manufacturing.
Pubmed ID: 30017246 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD49b
View all literature mentionsThis monoclonal targets CD29
View all literature mentionsThis monoclonal targets CD42a
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis monoclonal targets COL4A2 (N-term)
View all literature mentionsThis monoclonal targets VCAM1
View all literature mentionsThis monoclonal targets Fibrin alpha chain
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets HDAC6 (D21B10) Rabbit mAb
View all literature mentionsThis monoclonal targets alpha Tubulin
View all literature mentionsThis polyclonal targets anti-β1-Tubulin
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets CD32a
View all literature mentionsThis monoclonal targets CD42a
View all literature mentionsThis monoclonal targets CD62P
View all literature mentionsThis monoclonal targets CD235ab
View all literature mentionsThis monoclonal targets CD42b
View all literature mentionsThis monoclonal targets CD41
View all literature mentionsThis monoclonal targets CD49b
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
